Literature DB >> 12121778

Circular dichroism study of the irreversibility of conformational changes induced by polyamine-linked dinuclear platinum compounds.

Tracey D McGregor1, Wendi Bousfield, Yun Qu, Nicholas Farrell.   

Abstract

In this work, the reversibility of both the B-->Z and B-->A conformational change in polymer DNA induced by polynuclear platinum compounds was studied. The compounds examined were: [[trans-PtCl(NH(3))(2)](2)[NH(2) (CH(2))(6)NH(2)]](2+) (BBR3005); [[trans-PtCl(NH(3))(2)](2)[mu-spermine-N1,N12]](4+) (BBR3535); [[trans-PtCl(NH(3))(2)](2)[mu-spermidine-N1,N8]](3+) (BBR3571); [[trans-PtCl(NH(3))(2)](2)[mu-BOC-spermidine]](2+) (BBR3537); and [[trans-PtCl(NH(3))(2)](2)[mu-trans-Pt(NH(3))(2)(H(2)N(CH(2))(6)NH(2))(2)]](4+) (BBR3464). The conformational changes were assessed by circular dichroism and the reversibility of the transitions was tested by subsequent titration with the DNA intercalator ethidium bromide (EtBr). Fluorescent quenching was also used to assess the ability of ethidium bromide to intercalate into A and/or Z-DNA induced by the compounds. The results were compared with those produced by the simple hexamminecobalt cation [Co(NH(3))(6)](3+). The data suggest that while conformational changes induced by electrostatic interactions are confirmed to be reversible, covalent binding induces irreversible changes in both the A and Z conformation. The relevance of these changes to the novel biological action of polynuclear platinum compounds is discussed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12121778     DOI: 10.1016/s0162-0134(02)00398-7

Source DB:  PubMed          Journal:  J Inorg Biochem        ISSN: 0162-0134            Impact factor:   4.155


  6 in total

1.  Effects of geometric isomerism and anions on the kinetics and mechanism of the stepwise formation of long-range DNA interstrand cross-links by dinuclear platinum antitumor complexes.

Authors:  Junyong Zhang; Donald S Thomas; Susan J Berners-Price; Nicholas Farrell
Journal:  Chemistry       Date:  2008       Impact factor: 5.236

2.  Dinuclear platinum(II) complexes of imidazophenanthroline-based bridging ligands as potential anticancer agents: synthesis, characterization, and in vitro cytotoxicity studies.

Authors:  Carlson Alexander; N U Prajith; P V Priyanka; A Nithyakumar; N Arockia Samy
Journal:  J Biol Inorg Chem       Date:  2019-04-03       Impact factor: 3.358

Review 3.  The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs.

Authors:  Timothy C Johnstone; Kogularamanan Suntharalingam; Stephen J Lippard
Journal:  Chem Rev       Date:  2016-02-11       Impact factor: 60.622

4.  Differential recognition by the tumor suppressor protein p53 of DNA modified by the novel antitumor trinuclear platinum drug BBR3464 and cisplatin.

Authors:  Jana Kasparkova; Miroslav Fojta; Nicholas Farrell; Viktor Brabec
Journal:  Nucleic Acids Res       Date:  2004-10-14       Impact factor: 16.971

5.  Cyclometalated Iminophosphorane Gold(III) and Platinum(II) Complexes. A Highly Permeable Cationic Platinum(II) Compound with Promising Anticancer Properties.

Authors:  Malgorzata Frik; Jacob Fernández-Gallardo; Oscar Gonzalo; Víctor Mangas-Sanjuan; Marta González-Alvarez; Alfonso Serrano del Valle; Chunhua Hu; Isabel González-Alvarez; Marival Bermejo; Isabel Marzo; María Contel
Journal:  J Med Chem       Date:  2015-07-22       Impact factor: 7.446

6.  Interaction between DNA and Drugs Having Protonable Basic Groups: Characterization through Affinity Constants, Drug Release Kinetics, and Conformational Changes.

Authors:  Liliana P Alarcón; Yolima Baena; Rubén H Manzo
Journal:  Sci Pharm       Date:  2017-01-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.